|
|
   Remdesivir
|
|
|
| appearance as argument number 1 |
|
|
| (documentation Remdesivir EnglishLanguage "Remdesivir, sold under the brand name Veklury, is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences. It is administered via injection into a vein. Some studies found antiviral activity against several RNAViruses including SARS Coronavirus and MERS Coronavirus, but it is not approved by the USFoodAndDrugAdministration for any indication. [in part from Wikipedia]") | VirusProteinAndCellPart.kif 1272-1277 | |
| (medicine Remdesivir Covid19) | VirusProteinAndCellPart.kif 1270-1270 | |
| (roomTempState Remdesivir Liquid) | Mid-level-ontology.kif 31644-31644 | |
| (subclass Remdesivir AntiViralMedicine) | VirusProteinAndCellPart.kif 1267-1267 |
| appearance as argument number 2 |
|
|
| (termFormat EnglishLanguage Remdesivir "Remdesivir") | VirusProteinAndCellPart.kif 1268-1268 | |
| (termFormat EnglishLanguage Remdesivir "Veklury") | VirusProteinAndCellPart.kif 1269-1269 |
|
|
|